losartan has been researched along with Brain Injuries in 3 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
Brain Injuries: Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nozaki, T | 1 |
| Ura, H | 1 |
| Takumi, I | 1 |
| Kobayashi, S | 1 |
| Maru, E | 1 |
| Morita, A | 1 |
| Friedman, A | 1 |
| Bar-Klein, G | 1 |
| Serlin, Y | 1 |
| Parmet, Y | 1 |
| Heinemann, U | 1 |
| Kaufer, D | 1 |
| Viswanathan, M | 1 |
| de Oliveira, AM | 1 |
| Wu, RM | 1 |
| Chiueh, CC | 1 |
| Saavedra, JM | 1 |
1 review available for losartan and Brain Injuries
| Article | Year |
|---|---|
Should losartan be administered following brain injury?
Topics: Animals; Blood-Brain Barrier; Brain; Brain Injuries; Humans; Losartan; Signal Transduction; Transfor | 2014 |
2 other studies available for losartan and Brain Injuries
| Article | Year |
|---|---|
The angiotensin II type I receptor antagonist losartan retards amygdala kindling-induced epileptogenesis.
Topics: Amygdala; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Brain Injuries; Cerebral | 2018 |
[125I]CGP 42112 reveals a non-angiotensin II binding site in 1-methyl-4-phenylpyridine (MPP+)-induced brain injury.
Topics: 1-Methyl-4-phenylpyridinium; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoradiogra | 1994 |